Dear All,
In view of the numerous discussions we have on the important role patents can serve for drug repurposing programs (academic researchers, clinicians, etc., staying in control by controlling access to the relevant IP on the new use of the known drug), I advise to include the additional separate category “IP & patent strategy” in the list of Categories.
Vriendelijke groet,
Barend Bouma